Partner news
News
Partner news
BRIEF-Provention Bio Files For IPO Of Up To $50 Million
Read full storyPartner news
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
Read full storyPartner news